Definition
A very rare variant of intrahepatic bile duct carcinoma dominated by a clear cell morphology.
There is no association with cirrhosis.
The tumour may form a single or multiple masses.
The tumour shows a solid growth or papillary4 pattern. Towards the centre of the tumour, there are fibrotic areas. The tumour cells have clear vacuolated cytoplasm with distinct cell membranes. They have been variously reported as positive3 and negative1 for PAS. There may also be areas composed of cells with eosinophilic cytoplasm, forming glands. There may be an associated bile-duct adenoma like component, which may also be positive for CD56.
3/31, 1/12 |
|||
3/31 |
|||
3/31 |
|||
1/31 |
|||
0/31, 0/12 |
|||
3/31 |
|||
1/31 |
|||
2/31 |
|||
0/31, 1/12 |
|||
1/31 |
|||
p53 |
1/12 |
||
2/31 |
|||
0/31 |
|||
0/31 |
|||
2% to 5% of cells1, >50% of cells2 |
|||
0/31 |
|||
0/31 |
|||
0/31 |
|||
0/31 |
|||
0/31 |
|||
0/31 |
|||
The vacuoles are optically empty lipid droplets. There are scanty glycogen granules.
Bile duct adenoma, clear cell type: nuclear pleomoprhism is less marked.
Clear cell hepatocellular carcinoma: shows positivity for HepPar1, canalicular staining for CD10 and pCEA, and may be positive for AFP.
Metastatic clear cell carcinoma from:
Neuroendocrine tumours are positive for CD56 but also for chromogranin and synaptophysin.
These tumours may show aggressively metastatic behaviour.
This page last revised 30.6.2007.
©SMUHT/PW Bishop